Opening book details…
Can I read Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative on EtoBox?
Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative by Daniel J. Bertges; Art Sedrakyan; Tianyi Sun; Mohammad H. Eslami; Marc Schermerhorn; Philip P. Goodney; Adam W. Beck; Jack L. Cronenwett; Jens Eldrup-Jorgensen is a Medicine article available to read on EtoBox.
What is Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative about?
## Background: To compare mortality after treatment of superficial femoral-popliteal artery disease with paclitaxel and nonpaclitaxel devices using a multicenter vascular registry. ## Methods: Patients (N=8376) undergoing endovascular treatment of superficial femoral-popliteal artery disease in the Society for Vascular Surgery Vascular Quality Initiative were studied from October 2016 to December 2017. One-year mortality was compared between 3 groups; plain balloon angioplasty (N=2104) versus paclitaxel-coated balloon angioplasty (N=3543), bare-metal stenting (N= 2045) versus paclitaxel-eluting stents (N=684), and combined paclitaxel versus nonpaclitaxel devices. Mortality rates with hazard ratios (HR) and 95% CI were compared in unadjusted and propensity-matched cohorts and illustrated by Kaplan-Meier analysis with subgroup analysis for intermittent claudication, chronic limb-threatening ischemia, and secondary interventions. ## Results: In propensity-matched analyses, mortality was similar after plain balloon angioplasty (12.6%) and paclitaxel-coated balloon angioplasty (9.6%; HR=0.84 [95% CI, 0.66–1.06], P =0.14). In propensity-matched groups, mortality was similar after bare-me
Who reads Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Daniel J. Bertges; Art Sedrakyan; Tianyi Sun; Mohammad H. Eslami; Marc Schermerhorn; Philip P. Goodney; Adam W. Beck; Jack L. Cronenwett; Jens Eldrup-Jorgensen
- Publisher
- Ovid Technologies Wolters Kluwer -American Heart Association; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 1941-7640)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)